title: Is intensive cholesterol lowering detrimental in multiple sclerosis?
authors.forename: Luca
authors.initials: L
authors.lastname: Mascitelli
authors.forename: Mark R
authors.initials: MR
authors.lastname: Goldstein
mesh_terms: D000924:Anticholesteremic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D002784:Cholesterol / Q000096:biosynthesis*; D006801:Humans; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000378:metabolism*; D009186:Myelin Sheath / Q000378:metabolism*; D009836:Oligodendroglia / Q000378:metabolism*
chemical_list: D000924:Anticholesteremic Agents; D002784:Cholesterol